Prenatal fluoxetine exposure affects cytokine and behavioral response to an immune challenge

Journal of Neuroimmunology

Volumn 284, Issue , 2015, Pages 49-56

  Avitsur, Ronit ^a   Levy, Sigal ^a   Grinshpahet, Rachel ^a   Goren, Naama ^a   Hirsh, Ofer ^a   Zalko, Assaf ^a  

^a ACADEMIC COLLEGE OF TEL AVIV YAFFO   (Israel)

Author keywords

Antidepressant; Lipopolysaccharide (LPS); Prenatal environment; Proinflammatory cytokines; Serotonin selective reuptake inhibitors (SSRIs); Sickness behavior

Indexed keywords

CYTOKINE; ENDOTOXIN; FLUOXETINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; SUCROSE;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; COPING BEHAVIOR; CYTOKINE RELEASE; DEVELOPMENTAL STAGE; DRUG MECHANISM; FEMALE; FOOD INTAKE; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; SEROTONINERGIC SYSTEM; YOUNG ADULT; AGE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; DRUG EFFECTS; EATING; FOOD PREFERENCE; ILLNESS BEHAVIOR; INSTITUTE FOR CANCER RESEARCH MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY; SEX DIFFERENCE; TIME;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BODY WEIGHT; CYTOKINES; EATING; FEMALE; FLUOXETINE; FOOD PREFERENCES; ILLNESS BEHAVIOR; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX FACTORS; SUCROSE; TIME FACTORS;

EID: 84929852589     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.05.006     Document Type: Article

References (47)

1. Ahern G.P. 5-HT and the immune system. Curr. Opin. Pharmacol. 2011, 11(1):29-33.
2. Amireault P., Sibon D., Côté F. Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. ACS Chem. Neurosci. 2013, 4(1):64-71.
3. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306(5697):879-881.
4. Ansorge M.S., Morelli E., Gingrich J.A. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J. Neurosci. 2008, 28:199-207.
5. Avitsur R., Sheridan J.F. Neonatal stress modulates sickness behavior. Brain Behav. Immun. 2009, 23(7):977-985.
6. Avitsur R., Yirmiya R. The immunobiology of sexual behavior: gender differences in the suppression of sexual activity during illness. Pharmacol. Biochem. Behav. 1999, 64:787-796.
7. Avitsur R., Mays J.W., Sheridan J.F. Sex differences in the response to influenza virus infection: modulation by stress. Horm. Behav. 2011, 59(2):257-264.
8. Avitsur R., Maayan R., Weizman A. Neonatal stress modulates sickness behavior: role for proinflammatory cytokines. J. Neuroimmunol. 2013, 257(1-2):59-66.
9. Baganz N.L., Blakely R.D. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem. Neurosci. 2013, 4(1):48-63.
10. Bairy K.L., Madhyastha S., Ashok K.P., Bairy I., Malini S. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2007, 79(1):1-11.
11. Besedovsky H., Sorkin E., Felix D., Haas H. Hypothalamic changes during the immune response. Eur. J. Immunol. 1977, 7:323-325.
12. Cabrera-Vera T.M., Battaglia G. Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies. J. Pharmacol. Exp. Ther. 1998, 286(3):1474-1481.
13. Cabrera-Vera T.M., Garcia F., Pinto W., Battaglia G. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. J. Pharmacol. Exp. Ther. 1997, 280(1):138-145.
14. Castanon N., Leonard B.E., Neveu P.J., Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav. Immun. 2002, 16(5):569-574.
15. Chaouloff F. Serotonin, stress and corticoids. J. Psychopharmacol. 2000, 14(2):139-151.
16. Chaouloff F., Berton O., MormÉde P. Serotonin and stress. Neuropsychopharmacology 1999, 21:28S-32S.
17. Dantzer R., Bluthe R., Castanon N., Kelley K.W., Konsman J.P., Laye S., Lestage J., Parnet P. Cytokines, sickness behavior and depression. Psychoneuroimmunology 2007, 281-318. Elsevier. R. Ader (Ed.).
18. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36(3):426-436.
19. da-Silva V.A., Altenburg S.P., Malheiros L.R., Thomaz T.G., Lindsey C.J. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Braz. J. Med. Biol. Res. 1999, 32(1):93-98.
20. Davidson S., Prokonov D., Taler M., Maayan R., Harell D., Gil-Ad I., Weizman A. Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr. Res. 2009, 65(2):236-241.
21. Forcelli P.A., Heinrichs S.C. Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring. Addict. Biol. 2007, 13(1):52-62.
22. Francis-Oliveira J., Ponte B., Barbosa A.P., Veríssimo L.F., Gomes M.V., Pelosi G.G., Britto L.R., Moreira E.G. Fluoxetine exposure during pregnancy and lactation: effects on acute stress response and behavior in the novelty-suppressed feeding are age and gender-dependent in rats. Behav. Brain Res. 2013, 252:195-203.
23. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4(12):1002-1012.
24. Gobbi G., Murphy D.L., Lesch K., Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J. Pharmacol. Exp. Ther. 2001, 296:987-995.
25. Golde W.T., Gollobin P., Rodriguez L.L. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim. (NY) 2005, 34(9):39-43.
26. Hart B. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
27. Hendrick V., Stowe Z.N., Altshuler L.L., Hwang S., Lee E., Haynes D. Placental passage of antidepressant medications. Am. J. Psychiatry 2003, 160(5):993-996.
28. Hilli J., Heikkinen T., Rontu R., Lehtimäki T., Kishida I., Aklillu E., Bertilsson L., Vahlberg T., Laine K. MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. Eur. Neuropsychopharmacol. 2009, 19(5):363-370.
29. Homberg J.R., Schubert D., Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol. Sci. 2010, 31(2):60-65.
30. Kent S., Bluthe R., Kelley K., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 1992, 13:24-28.
31. Laine K., Heikkinen T., Ekblad U., Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch. Gen. Psychiatry 2003, 60:720-726.
32. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., Hofer M.A., Hen R., Gingrich J.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 2003, 54(10):960-971.
33. Lisboa S.F., Oliveira P.E., Costa L.C., Venâncio E.J., Moreira E.G. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 2007, 80(1):49-56.
34. Naka T., Nishimoto N., Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002, 4(Suppl. 3):S233-S242.
35. Oberlander T.F. Fetal serotonin signaling: setting pathways for early childhood development and behavior. J. Adolesc. Health 2012, 51(2 Suppl.):S9-S16.
36. Oberlander T.F., Eckstein Grunau R., Fitzgerald C., Ellwood A.L., Misri S., Rurak D., Riggs K.W. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr. Res. 2002, 51(4):443-453.
37. Oberlander T.F., Grunau R.E., Fitzgerald C., Papsdorf M., Rurak D., Riggs W. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005, 115(2):411-425.
38. Oberlander T.F., Gingrich J.A., Ansorge M.S. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin. Pharmacol. Ther. 2009, 86(6):672-677.
39. Oberlander T.F., Papsdorf M., Brain U.M., Misri S., Ross C., Grunau R.E. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3years of age. Arch. Pediatr. Adolesc. Med. 2010, 164(5):444-451.
40. O'Connor J.C., Lawson M.A., André C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14(5):511-522.
41. Olivier J.D., Blom T., Arentsen T., Homberg J.R. The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(6):1400-1408.
42. Olivier J.D., Vallès A., van Heesch F., Afrasiab-Middelman A., Roelofs J.J., Jonkers M., Peeters E.J., Korte-Bouws G.A., Dederen J.P., Kiliaan A.J., Martens G.J., Schubert D., Homberg J.R. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berlin) 2011, 217(3):419-432.
43. Prager G., Hadamitzky M., Engler A., Doenlen R., Wirth T., Pacheco-Lopez G., Krugel U., Schedlowski M., Engler H. Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B. J. Neuroimmune Pharmacol. 2013, 8:42-50.
44. Reddy M.S. Depression: the disorder and the burden. Indian J. Psychol. Med. 2010, 32(1):1-2.
45. Welbourn C.R., Young Y. Endotoxin, septic shock and acute lung injury, neutrophils, macrophages and inflammatory mediators. Br. J. Surg. 1992, 79:998-1003.
46. Whitaker-Azmitia P.M., Druse M., Walker P., Lauder J.M. Serotonin as a developmental signal. Behav. Brain Res. 1996, 73:19-29.
47. Yonkers K.A., Wisner K.L., Stewart D.E., Oberlander T.F., Dell D.L., Stotland N., Ramin S., Chaudron L., Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet. Gynecol. 2009, 114(3):703-713.